125 related articles for article (PubMed ID: 37824540)
1. Two-center validation of assays for the detection of binding and neutralizing anti-factor VIII antibodies.
Müller J; Neimanis S; Kahle J; Albert T; Schultze Strasser S; Rup B; Pötzsch B; Königs C; Oldenburg J;
Haemophilia; 2024 Jan; 30(1):224-231. PubMed ID: 37824540
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study.
Werwitzke S; Geisen U; Nowak-Göttl U; Eichler H; Stephan B; Scholz U; Holstein K; Klamroth R; Knöbl P; Huth-Kühne A; Bomke B; Tiede A
J Thromb Haemost; 2016 May; 14(5):940-7. PubMed ID: 26988717
[TBL] [Abstract][Full Text] [Related]
3. Methods for anti-factor VIII antibody levels in haemophilia A patients - validation of a multiplex immunoassay and comparability with assays measuring non-neutralising and neutralising antibodies (inhibitors).
Martin M; Augustsson C; Lind V; Al-Sabti R; Lam MC; Andersson NG; Strandberg K
Haemophilia; 2023 Jan; 29(1):336-347. PubMed ID: 36193002
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive domain-specific analysis and immunoglobulin G profiling of anti-factor VIII antibodies using a bead-based multiplex immunoassay.
Pezeshkpoor B; Berkemeier AC; Herbst K; Albert T; Müller J; Oldenburg J
J Thromb Haemost; 2024 Jun; 22(6):1591-1604. PubMed ID: 38453023
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of neutralizing and non-neutralizing anti-FVIII antibodies in a nationwide cohort of 788 persons with hemophilia A.
Oomen I; Verhagen M; Miranda M; Allacher P; Beckers EAM; Blijlevens NMA; van der Bom JG; Coppens M; Driessens M; Eikenboom JCJ; Fijnvandraat K; Hassan S; van Heerde WL; Hooimeijer HL; Jansen JH; Kaijen P; Leebeek FWG; Meijer D; Paul H; Rijpma SR; Rosendaal FR; Smit C; van Vulpen LFD; Voorberg J; Schols SEM; Gouw SC
Front Immunol; 2024; 15():1355813. PubMed ID: 38455035
[TBL] [Abstract][Full Text] [Related]
6. False-positive results in ELISA-based anti FVIII antibody assay may occur with lupus anticoagulant and phospholipid antibodies.
Sahud M; Zhukov O; Mo K; Popov J; Dlott J
Haemophilia; 2012 Sep; 18(5):777-81. PubMed ID: 22458845
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of anti-factor VIII IgG ELISA in acquired hemophilia A follow-up.
Chansavang A; Philippe A; Bozinovic I; Ben Hadj Ali K; Smadja D; Helley D; Darnige L; Mauge L
Ann Hematol; 2022 Nov; 101(11):2453-2460. PubMed ID: 36125542
[TBL] [Abstract][Full Text] [Related]
8. [Modified Bethesda, modified Nijmegen and blank assays for coagulation factor VIII inhibitor detection and factors affecting the results].
Feng HM; Li Q; Xu WS; Chen DM; Zheng L
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 36(4):592-5. PubMed ID: 27113194
[TBL] [Abstract][Full Text] [Related]
9. Limit of detection and threshold for positivity of the Centers for Disease Control and Prevention assay for factor VIII inhibitors.
Miller CH; Boylan B; Shapiro AD; Lentz SR; Wicklund BM;
J Thromb Haemost; 2017 Oct; 15(10):1971-1976. PubMed ID: 28795528
[TBL] [Abstract][Full Text] [Related]
10. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A.
Batty P; Moore GW; Platton S; Maloney JC; Palmer B; Bowles L; Pasi KJ; Rangarajan S; Hart DP
Thromb Haemost; 2015 Oct; 114(4):804-11. PubMed ID: 26063073
[TBL] [Abstract][Full Text] [Related]
12. Validation of 4% albumin as a diluent in the Bethesda Assay for FVIII inhibitors.
Kershaw GW; Chen LS; Jayakodi D; Dunkley SM
Thromb Res; 2013; 132(6):735-41. PubMed ID: 24119613
[TBL] [Abstract][Full Text] [Related]
13. Routine measurements of factor VIII activity and inhibitor titer in the presence of emicizumab utilizing anti-idiotype monoclonal antibodies.
Nogami K; Soeda T; Matsumoto T; Kawabe Y; Kitazawa T; Shima M
J Thromb Haemost; 2018 Jul; 16(7):1383-1390. PubMed ID: 29734520
[TBL] [Abstract][Full Text] [Related]
14. The Nijmegen ultra-sensitive Bethesda Assay detects very low-titer factor VIII inhibitors in patients with congenital and acquired hemophilia A.
Valke LLFG; Verhagen MJA; Mulders BTPM; Polenewen R; Blijlevens NMA; Jansen JH; Mansouritorghabeh H; Elsheikh E; Reipert BM; Turecek PL; O'Donnell JS; Rijpma SR; Schols SEM; van Heerde WL; Meijer D
Thromb Res; 2023 Nov; 231():112-120. PubMed ID: 37844518
[TBL] [Abstract][Full Text] [Related]
15. An ELISA system to detect anti-factor VIII antibodies without interference by lupus anticoagulants. Preliminary data in hemophilia A patients.
Blanco AN; Peirano AA; Grosso SH; Gennari LC; Bianco RP; Lazzari MA
Haematologica; 2000 Oct; 85(10):1045-50. PubMed ID: 11025595
[TBL] [Abstract][Full Text] [Related]
16. Antidrug antibodies against the polyethylene glycol moiety inhibit the procoagulant activity of therapeutic polyethylene glycolated factor VIII.
Pezeshkpoor B; Sereda N; Berkemeier AC; Matuschek I; Schwarz N; Turecek PL; Horneff S; Klein C; Goldmann G; Marquardt N; Albert T; Müller J; Oldenburg J
J Thromb Haemost; 2023 Jun; 21(6):1503-1514. PubMed ID: 36934798
[TBL] [Abstract][Full Text] [Related]
17. Characterization of inhibitors to FVIII with an ELISA in congenital and acquired haemophilia A.
Lindgren A; Wadenvik H; Tengborn L
Haemophilia; 2002 Sep; 8(5):644-8. PubMed ID: 12199673
[TBL] [Abstract][Full Text] [Related]
18. Anti-C1 domain antibodies that accelerate factor VIII clearance contribute to antibody pathogenicity in a murine hemophilia A model.
Batsuli G; Ito J; Mercer R; Baldwin WH; Cox C; Parker ET; Healey JF; Lollar P; Meeks SL
J Thromb Haemost; 2018 Sep; 16(9):1779-1788. PubMed ID: 29981270
[TBL] [Abstract][Full Text] [Related]
19. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients.
Whelan SF; Hofbauer CJ; Horling FM; Allacher P; Wolfsegger MJ; Oldenburg J; Male C; Windyga J; Tiede A; Schwarz HP; Scheiflinger F; Reipert BM
Blood; 2013 Feb; 121(6):1039-48. PubMed ID: 23243272
[TBL] [Abstract][Full Text] [Related]
20. Effects of pre-analytical heat treatment in factor VIII (FVIII) inhibitor assays on FVIII antibody levels.
Boylan B; Miller CH
Haemophilia; 2018 May; 24(3):487-491. PubMed ID: 29461004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
